i really enjoy listening to what SP has to say in all of his presentations.
what i find particularly enjoyable is that they state in this pr, see highlight below, that they post relevant information on their website. why is that they don't talk about not being able to treat the condition(s) in the cns. i guess the blood brain barrier isn't a concern to them.
how on earth does this guy get this valuation for only having an enzyme that kinda works?
LEXINGTON, Mass., Feb. 25, 2015 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced today its presentation at the upcoming Cowen and Company 35th Annual Health Care Conference in Boston, MA.
Sanj K. Patel, President and Chief Executive Officer of Synageva, will present on Tuesday, March 3, 2015, at 8:00 a.m. EST. The presentation will be webcast live and may be accessed from the Investor Relations section of Synageva's website at www.synageva.com.
Synageva routinely posts information that may be important to investors in the Investor Relations section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.
Further information regarding Synageva is available at www.synageva.com.
"Synageva BioPharma™" is a trademark, and "Dedicated to Rare Diseases®" is a registered trademark, of Synageva BioPharma Corp.
Logo - https://photos.prnewswire.com/prnh/20140522/90728
To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/synageva-biopharma-to-present-at-the-cowen-and-company-health-care-conference-300041286.html
SOURCE Synageva BioPharma Corp.